Get the Stockscreener App
8.07
2.42%
-0.20
After Hours:
8.15
0.08
+0.99%
Rezolute Inc stock is traded at $8.07, with a volume of 1.86M.
It is down -2.42% in the last 24 hours and up +4.94% over the past month.
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
See More
Previous Close:
$8.27
Open:
$8.42
24h Volume:
1.86M
Relative Volume:
1.71
Market Cap:
$732.85M
Revenue:
-
Net Income/Loss:
$-69.31M
P/E Ratio:
-6.3543
EPS:
-1.27
Net Cash Flow:
$-62.80M
1W Performance:
-8.40%
1M Performance:
+4.94%
6M Performance:
+226.72%
1Y Performance:
+71.70%
1-Day Range:
$8.04
$8.42
1-Week Range:
$8.04
$9.2899
52-Week Range:
$2.215
$9.7234
Rezolute Inc Stock (RZLT) Company Profile
Name
Rezolute Inc
Sector
Industry
Phone
650-206-4507
Address
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Compare RZLT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
8.07 | 751.15M | 0 | -69.31M | -62.80M | -1.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-24 | Initiated | Wedbush | Outperform |
| Aug-27-24 | Initiated | Guggenheim | Buy |
| Jul-17-24 | Initiated | BTIG Research | Buy |
| Jun-04-24 | Initiated | Craig Hallum | Buy |
| Apr-09-24 | Initiated | Maxim Group | Buy |
| Aug-02-22 | Resumed | Canaccord Genuity | Buy |
| Jun-15-22 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-08-21 | Initiated | ROTH Capital | Buy |
| May-27-21 | Initiated | Oppenheimer | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
View All
Rezolute Inc Stock (RZLT) Latest News
Using RSI to spot recovery in Rezolute Inc.2025 Key Highlights & Technical Pattern Based Signals - newser.com
Applying Wyckoff theory to Rezolute Inc. stockJuly 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com
Will Rezolute Inc. stock benefit from infrastructure spendingMarket Performance Recap & Safe Entry Momentum Tips - newser.com
Using R and stats models for Rezolute Inc. forecastingTrade Risk Summary & Free Growth Oriented Trading Recommendations - newser.com
Rezolute Announces Inducement Grant under Nasdaq Listing Rule 5635(4) - MarketScreener
Can Rezolute Inc. stock sustain free cash flow growthMarket Trend Review & High Conviction Buy Zone Alerts - newser.com
What candlestick patterns are forming on Rezolute Inc.Insider Selling & Weekly Return Optimization Plans - newser.com
Is Rezolute Inc. stock a smart buy before Fed meetingJuly 2025 Action & AI Enhanced Trading Alerts - newser.com
Rezolute announces inducement grant under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
125K Options: Rezolute Grants Inducement Awards with $9.40 Exercise Price, 10‑Year Term - Stock Titan
Rezolute Inc. stock momentum explainedEarnings Recap Report & Daily Oversold Stock Bounce Ideas - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Rezolute (NASDAQ:RZLT) - MarketBeat
Rezolute, Inc. ($RZLT) CEO 2025 Pay Revealed - Quiver Quantitative
What drives Rezolute Inc stock priceMarket Insider Reports & Exceptional Profit Growth Tips - earlytimes.in
What analysts say about Rezolute Inc 6HV1 stockMarket Sentiment Report & Low Entry Investment Ideas - earlytimes.in
What momentum shifts mean for Rezolute Inc.July 2025 Drop Watch & Stepwise Trade Execution Plans - newser.com
Strategies to average down on Rezolute Inc.2025 Growth vs Value & Safe Entry Momentum Stock Tips - newser.com
Is Rezolute Inc. stock ready for a breakoutTrade Risk Summary & Free High Return Stock Watch Alerts - newser.com
What earnings revisions data tells us about Rezolute Inc.Weekly Profit Analysis & Reliable Volume Spike Alerts - newser.com
Why Rezolute Inc. (6HV1) stock is favored by hedge funds2025 Performance Recap & High Conviction Investment Ideas - newser.com
Building trade automation scripts for Rezolute Inc.July 2025 Gainers & Weekly Sector Rotation Insights - newser.com
Institutional scanner results for Rezolute Inc.Dividend Hike & Stepwise Trade Execution Plans - newser.com
Identifying reversal signals in Rezolute Inc.2025 Market Trends & Weekly Consistent Profit Watchlists - newser.com
Volatility clustering patterns for Rezolute Inc.Weekly Profit Report & Long-Term Growth Portfolio Plans - newser.com
Is Rezolute Inc. (6HV1) stock attractive post correctionWeekly Stock Report & Fast Moving Trade Plans - newser.com
Rezolute (NASDAQ:RZLT) Sets New 1-Year HighStill a Buy? - MarketBeat
Maxim Group Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $15 - 富途牛牛
Cantor Fitzgerald Lowers Earnings Estimates for Rezolute - Defense World
Cantor Fitzgerald Weighs in on Rezolute FY2026 Earnings - MarketBeat
Is Rezolute Inc 6HV1 a good long term investmentPrice Momentum Alerts & 5 Stocks Every Investor Should Own - earlytimes.in
We're Not Very Worried About Rezolute's (NASDAQ:RZLT) Cash Burn Rate - Yahoo Finance
Rezolute Inc Stock (RZLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Rezolute Inc Stock (RZLT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Evans Daron | CFO |
Jun 24 '25 |
Buy |
4.05 |
5,000 |
20,250 |
268,900 |
| Kim Young-Jin | Director |
Jun 13 '25 |
Buy |
3.25 |
1,230,769 |
3,999,999 |
8,423,386 |
| KREHER NERISSA | Director |
Jun 13 '25 |
Buy |
3.25 |
3,076 |
9,997 |
37,576 |
| Hogenhuis Wladimir | Director |
Mar 31 '25 |
Buy |
2.92 |
6,758 |
19,733 |
84,025 |
| Elam Nevan C | CEO |
Mar 27 '25 |
Buy |
2.85 |
12,302 |
34,999 |
224,119 |
| Evans Daron | CFO |
Mar 26 '25 |
Buy |
2.89 |
10,000 |
28,900 |
237,900 |
| Evans Daron | CFO |
Mar 26 '25 |
Buy |
2.88 |
10,000 |
28,800 |
23,000 |
| Hogenhuis Wladimir | Director |
Feb 18 '25 |
Buy |
4.70 |
10,000 |
47,000 |
77,267 |
| Evans Daron | CFO |
Dec 18 '24 |
Buy |
4.29 |
10,000 |
42,900 |
150,900 |
| Evans Daron | CFO |
Dec 12 '24 |
Buy |
4.60 |
9,000 |
41,400 |
140,900 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):